The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia
OBJECTIVE: Familial hypercholesterolaemia (FH) affects 1 in 500 people in the UK population and is associated with premature morbidity and mortality from coronary heart disease. In 2008, National Institute for Health and Care Excellence (NICE) recommended genetic testing of potential FH index cases...
Main Authors: | Pears, R. (Author), Griffin, M. (Author), Watson, M. (Author), Wheeler, R. (Author), Hilder, D. (Author), Meeson, B. (Author), Bacon, S. (Author), Byrne, Christopher D. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2014-08-12.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Importance of early recognition of heterozygous familial hypercholesterolaemia
by: Ryan, A., et al.
Published: (2015) -
Preclinical atherosclerosis in monogenic familial hypercholesterolaemia and polygenic hypercholesterolaemia
by: Sharifi, Mahtab
Published: (2018) -
Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
by: Marks, et al.
Published: (2000-01-01) -
The genetic architecture of familial hypercholesterolaemia
by: Futema, M.
Published: (2014) -
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
by: Abbaszadegan, M.R, et al.
Published: (2018)